HAT1 and leiomyosarcoma of the corpus uteri: Researchers investigating the potential therapeutic benefits of uterine leiomyosarcoma have discovered that a combination of Pazopanib and heat inhibits the production of histone acetyltransferase 1, which in turn inhibits the growth of uterine leiomyosarcoma (HAT1).